Showing 1 posts of 1 posts found.
Valeant (NYSE: VRX) has announced that the ad hoc committee of the board of directors has finished its review of …
MHRA approves first lower-carbon beclometasone inhalers for asthma
Samsung Biologics launches bid to acquire peptide CDMO PolyPeptide
Novogenia breaks ground on personalised healthcare campus
InfectoPharm launches Polish operations with first hospital antibiotic
FibroFind appoints Lee Borthwick as CEO